Treatment Information

Back

Breast Cancer treatment details. Chemotherapy, Biologic therapy.

Hospital Universitario de Valme, Sevilla, Spain.

Survival: monthsCountry:Spain
Toxiciy Grade:5City/State/Province:Sevilla
Treatments:Chemotherapy, Biologic therapyHospital:Hospital Universitario de Valme
Drugs:Journal:Link
Date:Aug 2014

Description:

Patients:
This phase 2 study involved 90 metastatic breast cancer patients. The median patient age was 52 years and 99% were female.

Treatment:
Patients received chemotherapy with paclitaxel and gemcitabine, and biologic therapy with bevacizumab.

Toxicities:
Treatment-related deaths due to allergic reaction and infection were reported. Grade 4 rash and grade 3 neurological toxicity were also reported.

Results:
The median overall survival was 27.4 months.

Support:
This study was supported by Roche Pharma.

Correspondence: Dr. J. Salvador; email: [email protected]



Back